Tag: Remdesivir

Attorneys Report Spike in Calls for Help From Families of Patients Hospitalized With COVID-19

Attorneys around the country report an alarming uptick in calls for help from families of patients hospitalized with COVID-19. Some say they’ve talked to family members who were arrested after trying to visit a loved one or to speak with a doctor after communications with the hospital were cut off. Attorneys told The Epoch Times…


Combination of Remdesivir and Antibodies Didn’t Work Against COVID-19: Study

A combination of remdesivir and a concentrated solution of antibodies did not work well in people hospitalized with COVID-19, according to a newly published study. The clinical trial tested remdesivir, an antiviral from Gilead Sciences, combined with anti-coronavirus hyperimmune intravenous immunoglobulin (hIVIG), the concentrated solution that, but the combination did not significantly improve favorable outcomes among the…


US Regulators Clear Remdesivir for COVID-19 Outpatient Use

Some patients seeking treatment outside hospitals can now use the antiviral remdesivir after U.S. drug regulators late Friday expanded approval of the drug. The Food and Drug Administration (FDA) said the expansion was supported by a study run by Gilead Sciences, which developed remdesivir, showing the drug cut the risk of hospitalization by 87 percent…


Pennsylvania COVID-19 Patient Fights for Access to Ivermectin

YORK, Pennsylvania—Keith Smith received the first of three doses of ivermectin Monday, while being treated for COVID-19 in the intensive care unit at UPMC Memorial Hospital; the York, Pennsylvania hospital objected to the treatment, but Keith’s wife Darla Smith got a court order to allow it. “Ivermectin has been prescribed for human use for 35…


Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

“These drugs have been suppressed… for reasons that have nothing to do with the science and the medicine.” In this episode, we sit down with Dr. Harvey Risch, a professor of epidemiology at the Yale School of Public Health and Yale School of Medicine. He says therapeutics, including hydroxychloroquine and ivermectin, can be highly effective…


Recordings Reveal Lockstep COVID-19 Protocols, Patient Isolation by Hospitals

Attorneys, medical doctors, and family members of COVID-19 victims have described and offered recordings of what the Truth for Health Foundation calls “horrific hospital violations of human rights,” including denial of intravenous fluids to patients, denial of access to patients by families, attorneys, and others, and imposition of remdesivir on patients despite risks of kidney and…


Remdesivir Reduced Risk of Hospitalization When Given to COVID-19 Patients Early: Study

The antiviral remdesivir treatment reduced the risk of hospitalization among COVID-19 patients when administered soon after they were diagnosed, according to a new study. Researchers found that remdesivir cut hospitalization risk by 87 percent compared to a placebo that half of the study participants received. Some 562 patients, all deemed at high-risk from COVID-19, were enrolled…


Rand Paul Discloses His Wife’s Investment in Company Behind Remdesivir, 16 Months Later

Sen. Rand Paul (R-Ky.) on Wednesday disclosed in documents that his wife bought stock in Gilead Sciences, which manufactures antiviral drugs, in February 2020—before the threat from the CCP virus was classified as a pandemic by the World Health Organization. Paul said that he missed the deadline for filing such disclosures by 16 months because…